These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4998089)

  • 1. [Study on the psychodynamic effect of dihydroergotoxin].
    Heiss R; Seus R; Fahrenberg J
    Arzneimittelforschung; 1971 Jun; 21(6):797-800. PubMed ID: 4998089
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of arterial insufficiency in the lower limbs by Hydergin. A double-blind, cross-over examination studied by plethysmography.
    Siggaard-Andersen J; Petersen FB; Ulrich J
    Angiology; 1971 Jun; 22(6):311-9. PubMed ID: 4997064
    [No Abstract]   [Full Text] [Related]  

  • 4. The action of ergot alkaloids (ergotamine and dihydroergotoxin) on the functional effects of cerebral ischemia in the cat.
    Boismare F; Streichenberger G
    Pharmacology; 1974; 12(3):152-9. PubMed ID: 4216904
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
    McConnachie RW
    Curr Med Res Opin; 1973; 1(8):463-8. PubMed ID: 4204090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)].
    Pires de Oliveira RS
    Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581
    [No Abstract]   [Full Text] [Related]  

  • 7. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 8. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 10. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of the effect of Hydergin in long-term trial. An interdisciplinary study].
    Herzfeld U; Christian W; Oswald WD; Ronge J; Wittgen M
    Med Klin; 1972 Sep; 67(35):1118-25. PubMed ID: 4627270
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on treatment with nicergoline in a group of patients with hemiplegia in a post-acute phase].
    Zucconi V; Bolaffio MT
    Minerva Med; 1974 Mar; 65(17):936-45. PubMed ID: 4151126
    [No Abstract]   [Full Text] [Related]  

  • 13. Emesis induced by the intracerebroventricular administration of hydergine and mechlorethamine hydrochloride.
    Papp RH; Hawkins HB; Share NN; Wang SC
    J Pharmacol Exp Ther; 1966 Nov; 154(2):333-8. PubMed ID: 4958820
    [No Abstract]   [Full Text] [Related]  

  • 14. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 15. Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.
    Rehman SA
    Curr Med Res Opin; 1973; 1(8):456-62. PubMed ID: 4204089
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine.
    Lu WJ; Huang JD; Lai ML
    J Clin Pharmacol; 2006 Jun; 46(6):628-34. PubMed ID: 16707409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Result of a clinical study with the hypotensive agent Briserin].
    Frithz G
    Ther Ggw; 1971 Aug; 110(8):1175-81. PubMed ID: 4999120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinicopharmacological study of hydergin].
    Fujita T
    Masui; 1965 Oct; 14(10):948-53. PubMed ID: 4955566
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study on associated drug in geriatrics].
    Zerman AM; Titta FP
    Arch Sci Med (Torino); 1967 Apr; 123(4):164-74. PubMed ID: 4974552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of drugs on cerebrovascular circulation with special regard to Hydergin].
    Radielović P
    Lijec Vjesn; 1971; 93(11):1227-32. PubMed ID: 5005614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.